Simultaneous Measurement of 11 Antibiotics for use in the Intensive Care Unit by Ultra Performance Liquid Chromatography-Tandem Mass SpectrometryShow others and affiliations
2022 (English)In: Therapeutic Drug Monitoring, ISSN 0163-4356, E-ISSN 1536-3694, Vol. 44, no 2, p. 308-318Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: Recent studies indicate that a high proportion of patients in the intensive care unit (ICU) fail to attain adequate antibiotic levels. Thus, there is a need to monitor the antibiotic concentration to ensure effective treatment. Herein, the authors aimed to develop an ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method for the simultaneous quantification of antimicrobials to assess individualized therapeutic drug monitoring (TDM).
METHODS: A UHPLC-MS/MS method with 11 antibiotics (ciprofloxacin, moxifloxacin, benzylpenicillin, levofloxacin, linezolid, rifampicin, meropenem, cloxacillin, cefotaxime, clindamycin, and piperacillin) was developed. Chromatographic separation was performed using a Kinetex biphenyl reversed-phase column, with gradient elution using 0.1% formic acid (FA) and methanol with 0.1% FA. Sample preparation was performed using methanol protein precipitation. The total run time was 5 min.
RESULTS: For all analytes, the inter-assay inaccuracies for calibrators were ≤5%. The inter-day inaccuracies for the quality controls (QCs) were ≤5% for all analytes. The inter-assay precision for calibration standards ranged between 1.42% and 6.11%. The inter-assay imprecision for QCs of all antibiotics and concentrations ranged between 3.60% and 16.1%. Inter-assay inaccuracy and imprecision for the QCs and calibration standards were ≤15% for all drugs, except benzylpenicillin.
CONCLUSION: A rapid UHPLC-MS/MS method was developed for the simultaneous quantification of 11 different antibiotics. Minimal sample preparation was required to ensure a rapid turnaround time. The method was applied to clinical samples collected from four ICUs.
Place, publisher, year, edition, pages
Philadelphia, PA, United States: Lippincott Williams & Wilkins, 2022. Vol. 44, no 2, p. 308-318
Keywords [en]
UHPLC-MS/MS; Antibiotics; Therapeutic drug monitoring; Critically ill patients; Clinical application
National Category
Analytical Chemistry
Identifiers
URN: urn:nbn:se:liu:diva-183609DOI: 10.1097/ftd.0000000000000911ISI: 000769195300007PubMedID: 34224537OAI: oai:DiVA.org:liu-183609DiVA, id: diva2:1644459
Note
Funding: Research Council of South-East Sweden (FORSS); Swedish Research CouncilSwedish Research CouncilEuropean Commission; Marianne and Marcus Wallenberg Foundation [DNR 2014/236-31]
2022-03-142022-03-142024-05-05Bibliographically approved